Fecal microbiota transplantation: past, present and future

Purpose of reviewFecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases. Recent findingsIt is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders. SummaryFMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.

[1]  A. Eschalier,et al.  Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome , 2012, Alimentary pharmacology & therapeutics.

[2]  A. Khoruts,et al.  Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection , 2012, The American Journal of Gastroenterology.

[3]  F. Mearin,et al.  Postinfectious Chronic Gut Dysfunction: From Bench to Bedside , 2012 .

[4]  S. Collins,et al.  The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. , 2009, Gastroenterology.

[5]  D. Paterson,et al.  Putting back the bugs: bacterial treatment relieves chronic diarrhoea , 1994, The Medical journal of Australia.

[6]  B. Finlay,et al.  Gut microbiota in health and disease. , 2010, Physiological reviews.

[7]  B. Aronsson,et al.  RELAPSING CLOSTRIDIUM DIFFICILE ENTEROCOLITIS CURED BY RECTAL INFUSION OF HOMOLOGOUS FAECES , 1983, The Lancet.

[8]  Henry C. Lin,et al.  Using Probiotics in Gastrointestinal Disorders , 2012 .

[9]  J. Rask-Madsen,et al.  BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS , 1989, The Lancet.

[10]  L. Brandt,et al.  Treatment of recurrent Clostridium difficile–associated diarrhea by administration of donated stool directly through a colonoscope , 2000, American Journal of Gastroenterology.

[11]  M. Owings,et al.  Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging Infectious Diseases.

[12]  T. Borody,et al.  Bowel‐flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? , 1989, The Medical journal of Australia.

[13]  M. Kollef,et al.  Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005 , 2008, Emerging infectious diseases.

[14]  Jackson Jm,et al.  Letter: Haemophilic women. , 1973 .

[15]  Guang-xi Li,et al.  Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the Society for Healthcare Epidemiology of America(SHEA)and the Infectious Diseases Society of America(IDSA) , 2011 .

[16]  J. Jansson,et al.  Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea , 2009, Journal of clinical gastroenterology.

[17]  R. Spiller,et al.  Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. , 2003, Gastroenterology.

[18]  C. Gessert,et al.  STOOL TRANSPLANTATION FOR OLDER PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION , 2009, Journal of the American Geriatrics Society.

[19]  W. Chey,et al.  Manipulation of the Gut Microbiota as a Novel Treatment Strategy for Gastrointestinal Disorders , 2012 .

[20]  D. Pillai,et al.  Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  J. Bakken.  Fecal bacteriotherapy for recurrent Clostridium difficile infection. , 2009, Anaerobe.

[22]  T. Borody,et al.  Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora , 2010, Journal of clinical gastroenterology.

[23]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[24]  T. Borody,et al.  Bacteriotherapy Using Fecal Flora: Toying With Human Motions , 2004, Journal of clinical gastroenterology.

[25]  J. Bennet,et al.  TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORA , 1989, The Lancet.

[26]  J. Bakken,et al.  Treating Clostridium difficile infection with fecal microbiota transplantation. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[27]  M. Tvede,et al.  Bacteriotherapy for chronic relapsing Clostridium difficile in six patients , 1989 .

[28]  A. Berstad,et al.  [Clostridium difficile-associated diarrhea treated with homologous feces]. , 1998, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[29]  A. Manges,et al.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  L. Brandt,et al.  Fecal microbiota transplantation for recurrent Clostridium difficile infection , 2018, Canadian Medical Association Journal.

[31]  J. Marshall,et al.  S1223 Fecal Transplantation via Retention Enema is Effective for Recurrent or Refractory Clostridium difficile-Associated Diarrhea , 2010 .

[32]  C. Bernstein,et al.  Association Between the Use of Antibiotics and New Diagnoses of Crohn's Disease and Ulcerative Colitis , 2011, The American Journal of Gastroenterology.

[33]  M. A. Franzos,et al.  Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. , 2008, Annals of internal medicine.

[34]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[35]  C. Kelly,et al.  Clostridium difficile : Specific Pathogens , 2001 .

[36]  Anna Nowak,et al.  Reversal of Idiopathic Thrombocytopenic Purpura [ITP] with Fecal Microbiota Transplantation [FMT]: 941 , 2011 .

[37]  L. Brandt,et al.  Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation? , 2012, The American Journal of Gastroenterology.

[38]  C. Surawicz,et al.  Treatment of Recurrent Clostridium difficile Diarrhea. , 2006, Gastroenterology & hepatology.

[39]  C. Surawicz,et al.  Fecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and Methodology , 2010, Journal of clinical gastroenterology.

[40]  Brock Dj,et al.  Letter: Prospective diagnosis of spina bifida. , 1975 .

[41]  L. Gonzales.  Clostridium difficile , 2010, Methods in Molecular Biology™.

[42]  D. Frank,et al.  Impact of the Gut Microbiota on the Development of Obesity: Current Concepts , 2012 .

[43]  W. Silen,et al.  Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. , 1958, Surgery.

[44]  T. Borody,et al.  Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy , 2003, Journal of clinical gastroenterology.

[45]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Anil Ananthaswamy,et al.  Faecal transplant eases symptoms of Parkinson's disease , 2011 .

[47]  R. Seaton,et al.  Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. , 2009, QJM : monthly journal of the Association of Physicians.

[48]  Neil Stollman,et al.  Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection , 2012, The American Journal of Gastroenterology.

[49]  D. Antonopoulos,et al.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.

[50]  L. Brandt,et al.  Treatment of Refractory/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy: A Case Series of 12 Patients , 2010, Journal of clinical gastroenterology.

[51]  G. Russell,et al.  Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection in a Child: A Proposed Treatment Protocol , 2010, Pediatrics.

[52]  T. Borody,et al.  Fecal microbiota transplantation and emerging applications , 2012, Nature Reviews Gastroenterology &Hepatology.

[53]  Haroun Shah,et al.  Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  S. Mazmanian,et al.  Intestinal Microbes in Inflammatory Bowel Diseases , 2012 .

[55]  J. Bakken,et al.  Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.